Articles

A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells

Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden
Division of Molecular Hematology, Lund Stem Cell Center, Lund University, Lund, Sweden
Division of Hematology, Oncology and Bone Marrow Transplantation, University of Alabama at Birmingham, Birmingham, AL, USA
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden
Division of Molecular Hematology, Lund Stem Cell Center, Lund University, Lund, Sweden;Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden
Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Division of Hematology, Oncology and Bone Marrow Transplantation, University of Alabama at Birmingham, Birmingham, AL, USA
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden
Vol. 105 No. 8 (2020): August, 2020 https://doi.org/10.3324/haematol.2019.220434